Acila Pharmaceuticals Pvt Ltd
About Acila Pharmaceuticals Pvt Ltd
Data last updated:
Acila Pharmaceuticals Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 February 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1979PTC031871. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.37 Lakh. It is led by directors including Bappaditya Majumdar and Pijush Bhowmick.
Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office is at 176/H/9 Manicktala Main Road P S Phool Bagan, Kolkata, West Bengal, India – 700054.
As per MCA filings, the company has open charges of ₹6 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address176/H/9 Manicktala Main Road P S Phool Bagan, Kolkata, West Bengal, India – 700054
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Acila Pharmaceuticals Pvt Ltd FY 2015 filings available
Financial Statement Summary of Acila Pharmaceuticals Pvt Ltd
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Acila Pharmaceuticals Pvt Ltd
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acila Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Acila Pharmaceuticals Pvt Ltd
Acila Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bappaditya Majumdar Also directs: Acila Healthcare Private Limited | Director | 27 Jul 2012 | 14 Years 2 Months | Current |
| Pijush Bhowmick | Director | 03 Jun 1999 | 27 Years 4 Months | Current |
| Chandrani Chakraborty | Director | 03 Jun 1999 | 27 Years 4 Months | Current |
Auditor Details of Acila Pharmaceuticals Pvt Ltd
Acila Pharmaceuticals Pvt Ltd is audited by ASIM KUMAR DE & CO for the financial year 2015.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASIM KUMAR DE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Acila Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Acila Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 1980 | Uco Bank | ₹6 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Acila Pharmaceuticals Pvt Ltd
Acila Pharmaceuticals Pvt Ltd has 2 court cases on record: 2 filed by Acila Pharmaceuticals. All cases are disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Writ petition | Filed by the company against Union of India | Disposed |
| Calcutta High Court | Writ petition | Filed by the company against State of W.B | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Acila Pharmaceuticals Pvt Ltd
Employment history and EPFO contributions of people linked to Acila Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Acila Pharmaceuticals Pvt Ltd
Acila Pharmaceuticals Pvt Ltd has 3 board changes on record since 1999: 3 appointments. The latest: Bappaditya Majumdar was appointed as Director on 27 Jul 2012.
Credit Ratings, Litigation & Regulatory Alerts for Acila Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acila Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acila Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acila Pharmaceuticals Pvt Ltd
Acila Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acila Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acila Pharmaceuticals Pvt Ltd
Acila Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 February 1979 (47+ years old) and is registered under CIN U24231WB1979PTC031871.
Acila Pharmaceuticals has 3 current directors:
- Bappaditya Majumdar - Director
- Pijush Bhowmick - Director
- Chandrani Chakraborty - Director
No. Acila Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Acila Pharmaceuticals is U24231WB1979PTC031871. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acila Pharmaceuticals has 2 court cases on record: 2 filed by the company.
Acila Pharmaceuticals was incorporated on 08 February 1979, making it 47+ years old. It is registered with the Registrar of Companies, Kolkata.
Bappaditya Majumdar was appointed as Director on 27 Jul 2012. Chandrani Chakraborty was appointed as Director on 03 Jun 1999. Pijush Bhowmick was appointed as Director on 03 Jun 1999.
The registered office of Acila Pharmaceuticals is at 176H9 Manicktala Main Road P S Phool Bagan, Kolkata, West Bengal, India – 700054.
Acila Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.37 Lakh.
Acila Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.